Advancements in Precision Oncology: Metastatic NSCLC Treatment Landscape

Opinion
Video

Explore the dynamic landscape of metastatic non-squamous non-small cell lung cancer treatment, focusing on molecular genotyping, targeted therapies, and the evolving standard of care.

Related Videos
Mark A. Socinski, MD, an expert on lung cancer, presenting slides
A panel of 4 experts on bladder cancer seated at a long table
A panel of 4 experts on bladder cancer seated at a long table
A panel of 5 experts on lung cancer seated at a long table
A panel of 5 experts on lung cancer seated at a long table
Jason Porter, MD
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer
Related Content
Lyudmila A. Bazhenova, MD

Multidisciplinary Collaboration and Molecular Testing Are Integral to Treatment Decision-Making in NSCLC

November 30th 2023
Article
Hari B. Keshava, MD

Keshava Emphasizes the Importance of Lung Nodule Programs for Early Lung Cancer Detection

October 23rd 2023
Podcast
Biagio Ricciuti, MD

Long-Term Survival Benefit With PD-1 Monotherapy Correlated With High PD-L1 Expression in Advanced NSCLC

November 29th 2023
Article
Adnan F. Danish, MD

Danish Discusses the Benefits of SCINTIX Biology-Guided Radiotherapy in Metastatic Lung and Bone Cancers

August 7th 2023
Podcast
Yu Wang, MD, PhD, chief medical officer of GenFleet

IBI351 NDA Under NMPA Review in Advanced KRAS G12C–Mutant NSCLC

November 28th 2023
Article
Konstantinos Arnaoutakis, MD

Increasingly Specialized Clinical Trials Accelerate Advances in NSCLC Management

November 27th 2023
Article